Heart failure & cardiomyopathies

Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders: The EXCALIBUR Study

J Am Coll CardiolPublished Prospective cohort study

Authors' conclusion

In CA, clinically significant arrhythmias are common and frequently asymptomatic. Arrhythmic burden and patterns differ between amyloid subtypes and are closely associated with disease phenotype and myocardial amyloid burden.

Study context

Population
Treatment-naïve patients with new diagnosis of ATTR-CM or AL-CA, monitored with implantable loop recorders
Participants
110 patients
Exposure
ATTR-CM vs AL-CA
  • ATTRwt-CMn = 43
  • ATTRv-CMn = 20
  • AL-CAn = 47reference
Outcome
Bradyarrhythmias with Class I pacemaker indication
Methodological detailssingle-centre, observational
  • Single-centre
  • Observational

Main finding

As reported in the abstract

P = 0.036

Overall bradyarrhythmias with Class I pacemaker indication
17.3%
QRS duration and bradyarrhythmic events (sHR)
1.03 (95% CI 1.01-1.04; P < 0.001)
ECV and bradyarrhythmic events (sHR)
1.06 (95% CI 1.02-1.10; P = 0.002)

Observational data: associations, not effects.

Further findings

OutcomeAL-CAP value
New AF (no prior AF)ATTR-CM vs AL-CA12.2%P < 0.001
Death during follow-up23.4%
New AF (no prior AF) — Overall new AF
28.2%
New AF (no prior AF) — ECV and new AF (sHR)
1.04 (95% CI 1.00-1.08; P = 0.038)
Death during follow-up — Overall deaths
21 (19.1%)
Death during follow-up — Terminal rhythm in AL-CA: PEA
9 (81.8%)
Death during follow-up — Terminal rhythm in AL-CA: sustained ventricular arrhythmias
2 (18.2%)
  • New AF (no prior AF): ATTR-CM 50.0%
  • Death during follow-up: ATTR-CM 15.9%

Death during follow-up

Terminal rhythm in ATTR-CM: uniformly pulseless electrical activity

Original publication

Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders: The EXCALIBUR Study. J Am Coll Cardiol. Published 10 May 2026. doi:10.1016/j.jacc.2026.04.030

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.